Most integration failures between serialization and traceability systems come down to the same core problems:
Add in the complexity of multi-site manufacturing, contract packaging, and the ongoing demands of DSCSA compliance, and it's easy to see why traceability system integration is one of the most persistently difficult challenges in pharmaceutical and supply chain operations.
Organizations that understand these failure points before implementation — rather than after — are the ones that avoid the rework, compliance exposure, and operational disruption that come with getting it wrong.
Before diagnosing failure points, it's worth being precise about what integration means in this context.
In a serialization and traceability environment, integration refers to the seamless exchange of serialization data — serial numbers, lot numbers, expiration dates, aggregation data, and supply chain events — between systems operating at different levels of the serialization hierarchy:
When these layers don't communicate reliably, serialization data gets lost, duplicated, or corrupted — and what should be a continuous chain of custody becomes a series of gaps.
EPCIS (Electronic Product Code Information Services) is the GS1-developed standard for sharing supply chain event data. In theory, any EPCIS-certified system should be able to exchange data with any other. In practice, implementation varies significantly.
Problems arise when:
As Pam Forster, compliance solutions program director at Inmar Intelligence, put it in a Packaging Digest interview: "Every system speaks the same EPCIS language, but with its own accent. And even small differences in how data is structured or timed can create exceptions that hold up product."
Key consideration: Before onboarding a new trading partner or serialization platform, confirm which version of EPCIS each system supports and how custom extensions are handled at the integration layer.
Master data — GTINs, GLNs (Global Location Numbers), product hierarchies, and lot information — must be consistent across every system in the chain. If a brand owner's ERP has a different GTIN structure than what's registered in the packaging line system, serialization events won't match and the data becomes unreliable for compliance purposes.
Common master data problems include:
These errors are deceptively small. A one-digit formatting difference in a GTIN can render an entire lot's serialization data non-compliant, triggering costly rework or holds.
Key consideration: Master data alignment should be audited across all connected systems before go-live — and revisited any time a new product, site, or trading partner is added.
In a typical pharmaceutical supply chain, a single product may pass through a brand owner, one or more contract manufacturers, a wholesale distributor, and a pharmacy. Each entity may use a different serialization platform, different ERP, and different messaging infrastructure.
Without a well-defined integration architecture — covering how data is exchanged, when, and in what format — serialization events get dropped or arrive out of sequence. This is especially problematic for DSCSA compliance, which requires the complete transaction history to follow the product.
Key architecture decisions that affect integration reliability:
Key consideration: Map the full data flow between every trading partner before implementation — including failure scenarios — and document who is responsible for resolving errors at each handoff point.
Contract manufacturers (CMOs) often work with multiple brand owner clients simultaneously — each of whom may use a different Level 5 serialization repository. A CMO packaging products for three brand owners might need to send EPCIS events to three different cloud platforms, formatted differently for each.
Without a serialization gateway built to handle multi-client, multi-format communication, this becomes a manual and error-prone process — and one that carries real DSCSA compliance exposure if serialization data fails to reach the brand owner's system in the correct format before the product ships.
Key consideration: CMOs should document the serialization requirements of each brand owner client and evaluate whether their current infrastructure can handle format normalization at scale, or whether a dedicated gateway is needed.
Even when cloud-layer integration is solid, failures at the packaging line can undermine everything upstream. Common line-level integration problems include:
Key consideration: Line-level serialization performance should be monitored continuously — rejection rates, aggregation error rates, and misread frequencies are early indicators of integration problems that will surface further upstream if left unaddressed.
Serialization integrations break down over time without active maintenance. Software updates — whether to ERP systems, serialization platforms, or cloud repositories — are a common trigger.
This is particularly true for EPCIS version transitions. The move from EPCIS 1.2 to EPCIS 2.0 introduced changes to the data model that require updates to both sending and receiving systems. Organizations that upgraded one end of an integration without updating the other have encountered data exchange failures mid-operation.
Key consideration: Treat every system upgrade as a potential integration event. Regression testing against serialization data flows should be part of any change management process.
Many integration failures are discovered during production — not before it. Adequate pre-production testing of serialization and traceability system integration requires:
The temptation to compress validation timelines under compliance deadlines is understandable — but it's also one of the most common reasons organizations encounter integration problems after go-live.
Key consideration: Validation should be scoped to include realistic production data volumes and actual trading partner systems — not just internal test environments. Compressed timelines that skip this step tend to surface their costs quickly.
The Drug Supply Chain Security Act mandates electronic interoperability across the pharmaceutical supply chain. Under DSCSA, manufacturers, wholesale distributors, and dispensers must be able to verify, trace, and investigate suspect products — and that capability depends entirely on reliable serialization data flowing between systems.
The scale of the problem is significant. Informal industry polls suggest that around 98% of serialization data entering wholesalers is accurate — but at pharmaceutical supply chain volumes, that 2% error rate translates to an estimated 60 to 70 million quarantined units per year, with exceptions taking weeks to resolve.
The FDA has extended enforcement discretion timelines on multiple occasions, but those windows are finite. For pharmaceutical manufacturers, the cost of an integration failure can mean inability to ship product, failed saleable returns verification, and direct regulatory exposure.
Not all manufacturers face the same integration landscape. The complexity varies significantly depending on the operating environment.
|
Environment |
Primary Integration Challenges |
|
Single-site manufacturer |
ERP-to-serialization platform data sync; EPCIS event formatting |
|
Multi-site manufacturer |
Consistent master data across sites; centralized Level 5 repository management |
|
Contract manufacturer (CMO) |
Multi-brand-owner connectivity; format normalization across clients |
|
Outsourced packager |
Data handoff to brand owner; aggregation accuracy; DSCSA gateway compliance |
|
Distributor/3PL |
Inbound EPCIS event processing; VRS integration; saleable returns workflows |
The most common causes are incompatible data standards (particularly EPCIS version mismatches), master data misalignment, poorly defined communication architecture with trading partners, and insufficient pre-production testing. Contract manufacturing environments add complexity because a single CMO may need to exchange data with multiple brand owner systems in different formats.
EPCIS is the GS1 standard for exchanging supply chain event data — defining how serialization events are formatted and communicated between systems. Most integration failures trace back to inconsistent EPCIS implementation rather than the standard itself.
A contract manufacturer must send serialization data to the brand owner's traceability system in the format that system requires. Without a gateway to handle format translation, data can arrive incorrectly, be rejected, or not arrive at all — creating DSCSA compliance gaps.
A VRS allows pharmacies and distributors to verify a returned product's legitimacy before returning it to the saleable supply. It routes real-time verification requests to the correct manufacturer system — making it a critical integration point for DSCSA saleable returns compliance.
Any time a system component changes — a software upgrade, a new trading partner, a regulatory update, or a master data change — the affected integration flows should be re-validated. Integration is an ongoing operational responsibility, not a one-time implementation task.
Consolidating the serialization stack — hardware, software, and cloud — under a single vendor removes a significant category of failure before it starts. Integration points between the packaging line, site-level management, and Level 5 repository are engineered to work together rather than made to communicate after the fact. ERP connections, trading partner communications, and label printing systems still require management, but the internal misalignments that come from stitching together multi-vendor environments are largely eliminated.
Covectra operates as a single-source serialization provider with over 4 billion serial numbers issued worldwide. The core platform components include:
If you're working through a serialization integration challenge or evaluating your current environment, contact Covectra to discuss your specific situation.
Keep Reading